Company intelligence / Profile preview
Jiangsu Jiuxu Pharmaceutical
Jiangsu, Chinajiuxu.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Jiangsu Jiuxu Pharmaceutical is a China-based company focusing on traditional Chinese medicine compositions and small molecule drug manufacturing. They have patents related to a traditional herbal formula for metabolic syndrome and a nimodipine preparation, with at least two products in pre-clinical or commercialized stages within China. The company does not publicly disclose a broad clinical-stage pipeline typical of innovative biotech firms.
- Therapeutic areas
- Metabolic Disorders
- Modalities
- Small moleculeTraditional Chinese medicine composition
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Jiangsu Jiuxu Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiangsu Jiuxu Pharmaceutical.